Get the latest Science News and Discoveries

Active ingredient in Ozempic, Wegovy may reduce risk of Alzheimer's disease: Study

The active ingredient found in popular medications for Type 2 diabetes and weight loss, including Ozempic and Wegovy, may reduce the risk of Alzheimer's disease, a new study published Thursday finds. Semaglutide falls under a class of medications known as glucagon-like peptide-1 receptor agonists, or GLP-1s, which mimic the GLP-1 hormone that is produced in the gut after eating. It can help produce more insulin, which reduces blood sugar and therefore helps control Type 2 diabetes.

None

Get the Android app